Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/24/22
End: 01/24/23
Due: 01/24/24
Phase: N/A
Priority: Normal
Start: 11/22/22
End: 05/30/26
Due: 05/30/27
Phase: N/A
Priority: Normal
Start: 10/15/19
End: 12/15/21
Due: 12/15/22
Phase: N/A
Priority: Normal
Start: 11/20/20
End: 12/08/22
Due: 12/08/23
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A 16-Week Study of Pirenzepine or Placebo to Treat HIV-Associated Distal Sensory Polyneuropathy in Patients With HIV | NCT05005078 | WinSanTor, Inc | user2@example.com | None | 2022-02-24 | 2023-01-24 | 2024-01-24 | - | - | 2025-07-14 |
| A Study of Topical Pirenzepine or Placebo in Oncology Patients With Chemotherapy Induced Peripheral Neuropathy | NCT05488873 | WinSanTor, Inc | user2@example.com | None | 2022-11-22 | 2026-05-30 | 2027-05-30 | - | - | 2025-07-14 |
| A 24-Week Study of Topical Pirenzepine or Placebo in Type 2 Diabetic Patients (T2DM) With Peripheral Neuropathy | NCT04005287 | WinSanTor, Inc | user2@example.com | None | 2019-10-15 | 2021-12-15 | 2022-12-15 | - | - | 2025-07-14 |
| A 12-Week Study of Topical Pirenzepine or Placebo in Type 2 Diabetic Patients (T2DM) With Painful Peripheral Neuropathy | NCT04786340 | WinSanTor, Inc | user2@example.com | None | 2020-11-20 | 2022-12-08 | 2023-12-08 | - | - | 2025-07-14 |